omega-n-methylarginine has been researched along with Drug Withdrawal Symptoms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jain, R; Mohan, D; Mukherjee, K | 1 |
| Cappendijk, SL; de Vries, R; Dzoljic, MR | 1 |
| Kimes, AS; London, ED; Vaupel, DB | 2 |
| Dambisya, YM; Lee, TL | 1 |
| Bhargava, HN; Thorat, SN | 1 |
| Láinez, MJ; Monzón, MJ | 1 |
2 review(s) available for omega-n-methylarginine and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Inhibitors of nitric oxide synthase and the opioid withdrawal syndrome.
Topics: Animals; Arginine; Morphine Dependence; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Rats; Substance Withdrawal Syndrome | 1995 |
Chronic daily headache.
Topics: Adolescent; Adult; Aged; Analgesics; Botulinum Toxins, Type A; Clinical Trials as Topic; Comorbidity; Enzyme Inhibitors; Female; Genetic Predisposition to Disease; Headache Disorders; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Migraine Disorders; Nitric Oxide; Nitric Oxide Synthase; Nociceptors; omega-N-Methylarginine; Prognosis; Substance Withdrawal Syndrome; Substance-Related Disorders; Tension-Type Headache; Tomography, Emission-Computed; Trigeminal Nerve | 2001 |
5 other study(ies) available for omega-n-methylarginine and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Effects of nitric oxide synthase inhibitors in attenuating nicotine withdrawal in rats.
Topics: Animals; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Enzyme Inhibitors; Male; Mecamylamine; Motor Activity; NG-Nitroarginine Methyl Ester; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 2008 |
Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Behavior, Animal; Diarrhea; Male; Mice; Morphine Dependence; Naloxone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Substance Withdrawal Syndrome | 1993 |
Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Behavior, Animal; Dose-Response Relationship, Drug; Male; Morphine Dependence; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Inbred F344; Substance Withdrawal Syndrome; Weight Loss | 1993 |
Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice.
Topics: Animals; Arginine; Drug Interactions; Male; Mice; Morphine Dependence; Naloxone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Pain Measurement; Substance Withdrawal Syndrome | 1996 |
Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome.
Topics: Animals; Behavior, Animal; Central Nervous System; Dose-Response Relationship, Drug; Enzyme Inhibitors; Injections, Intraventricular; Male; Mice; Morphine Dependence; Naltrexone; Narcotic Antagonists; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Substance Withdrawal Syndrome | 1996 |